Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Minor version update from v3.4.1 to v3.4.2; no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T03:04:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Minor site-wide updates were made (revision v3.4.1 added and the funding-status notice removed), with no impact on study content or user tasks. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-09T22:33:11.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide funding-status notice was added, and a publication citation related to SWOG S1512 was included.
    Difference
    0.1%
    Check dated 2026-02-02T20:05:29.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Show glossary option has been added and the page now displays updated metadata labels, including Last Update Submitted that Met QC Criteria and Last Update Posted, plus Revision: v3.4.0. The older QC-related labels and the previous revision reference (Revision: v3.3.4) were removed.
    Difference
    0.1%
    Check dated 2026-01-26T21:57:29.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed, a minor site version update that does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T17:59:11.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing trial sites by state (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New York, North Carolina, Ohio, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, Wyoming) and a revision note (v3.3.3). This change replaces multiple individual state location subsections, altering how site availability is displayed to users.
    Difference
    0.9%
    Check dated 2025-12-22T01:23:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.